Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral Endocannabinoid System Dysregulation in First-Episode Psychosis
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 38, Issue 13, Pages 2568-2577
Publisher
Springer Nature
Online
2013-07-04
DOI
10.1038/npp.2013.165
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Endocannabinoid System and Schizophrenia: Integration of Evidence
- (2012) Erica Zamberletti et al. CURRENT PHARMACEUTICAL DESIGN
- Brain regional differences in CB1 receptor adaptation and regulation of transcription
- (2012) M.F. Lazenka et al. LIFE SCIENCES
- The role of endocannabinoids in gonadal function and fertility along the evolutionary axis
- (2012) Natalia Battista et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The endocannabinoid system in normal and pathological brain ageing
- (2012) A. Bilkei-Gorzo PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- New insights on endocannabinoid transmission in psychomotor disorders
- (2012) Andrea Giuffrida et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features
- (2012) Clemente Garcia-Rizo et al. PSYCHIATRY RESEARCH
- Toxoplasma gondii and Other Risk Factors for Schizophrenia: An Update
- (2012) E. F. Torrey et al. SCHIZOPHRENIA BULLETIN
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Criterios de valoración clínicos y de funcionamiento en un estudio de interacción gen-ambiente en primeros episodios psicóticos (PEPs)
- (2012) Miquel Bernardo et al. Revista de Psiquiatria y Salud Mental
- Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia
- (2012) Joëlle Desfossés et al. Frontiers in Psychiatry
- Identification of a biological signature for schizophrenia in serum
- (2011) E Schwarz et al. MOLECULAR PSYCHIATRY
- Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
- (2011) Antonio Ortega-Alvaro et al. NEUROPSYCHOPHARMACOLOGY
- Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence
- (2011) C.J. Hillard et al. NEUROSCIENCE
- Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond
- (2011) Urs Meyer et al. PHARMACOLOGY & THERAPEUTICS
- Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia
- (2011) Beng-Choon Ho et al. SCHIZOPHRENIA RESEARCH
- Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trial
- (2011) Douglas L. Boggs et al. SCHIZOPHRENIA RESEARCH
- EL CONCEPTO DE ESQUIZOFRENIA
- (2011) Brian Kirkpatrick Revista de Psiquiatria y Salud Mental
- International Consensus Study of Antipsychotic Dosing
- (2010) David M. Gardner et al. AMERICAN JOURNAL OF PSYCHIATRY
- Monoacylglycerol Lipase Activity Is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System
- (2010) P. K. Chanda et al. MOLECULAR PHARMACOLOGY
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation
- (2010) Silvia Zoppi et al. NEUROPSYCHOPHARMACOLOGY
- Brain Cannabinoid CB2 Receptor in Schizophrenia
- (2009) Hiroki Ishiguro et al. BIOLOGICAL PSYCHIATRY
- Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
- (2009) Dagmar Koethe et al. BRITISH JOURNAL OF PSYCHIATRY
- Cannabis and psychosis/schizophrenia: human studies
- (2009) Deepak Cyril D’Souza et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Cannabis use and age of diagnosis of schizophrenia
- (2009) Gisela Sugranyes et al. EUROPEAN PSYCHIATRY
- Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats
- (2009) Alexandre Seillier et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Rate of Cannabis Use Disorders in Clinical Samples of Patients With Schizophrenia: A Meta-analysis
- (2009) J. Koskinen et al. SCHIZOPHRENIA BULLETIN
- Substance Use Disorders in Schizophrenia--Clinical Implications of Comorbidity
- (2009) N. D. Volkow SCHIZOPHRENIA BULLETIN
- Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
- (2008) Stephen M. Eggan et al. ARCHIVES OF GENERAL PSYCHIATRY
- CNS Immune Surveillance and Neuroinflammation: Endocannabinoids Keep Control
- (2008) Susanne Wolf et al. CURRENT PHARMACEUTICAL DESIGN
- The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases
- (2008) Diego Centonze et al. CURRENT PHARMACEUTICAL DESIGN
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Cannabis use and brain structural alterations in first episode schizophrenia — A region of interest, voxel based morphometric study
- (2008) Srihari S. Bangalore et al. SCHIZOPHRENIA RESEARCH
- Antipsychotic Treatment in Child and Adolescent First-Episode Psychosis: A Longitudinal Naturalistic Approach
- (2007) Josefina Castro-Fornieles et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now